+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia



Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia



Hypertension 50(2): 269-275



Several studies have shown that hepatocytes can be generated from hematopoietic stem cells, but this event is believed to be rare and to require hepatic damage. To investigate this phenomenon in human cells, we used a NOD/SCID/gamma(c)null (NOG) mouse model that can achieve a tremendously high level of chimerism when transplanted with human hematopoietic cells.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 016714549

Download citation: RISBibTeXText

PMID: 17576854

DOI: 10.1161/hypertensionaha.107.091322


Related references

Elevated Transglutaminase Activity Triggers Angiotensin Receptor Activating Autoantibody Production and Pathophysiology of Preeclampsia. Journal of the American Heart Association 4(12):, 2015

Angiotensin receptor activating autoantibodies and the pathophysiology of preeclampsia. FASEB Journal 18(4-5): Abst 562 6, 2004

Progress toward identifying potential markers for preeclampsia: role of agonistic autoantibody to the angiotensin II type I receptor. Hypertension 55(2): 236-237, 2010

Response to questionable role of the angiotensin II receptor subtype 1 autoantibody in the pathogenesis of preeclampsia: There is no single universal preeclampsia cause. Hypertension (Baltimore) 50(1): E4, 2007

Angiotensin II type 1 receptor autoantibody as a novel regulator of aldosterone independent of preeclampsia. Journal of Hypertension 33(5): 1046-1056, 2015

Questionable role of the angiotensin II receptor subtype 1 autoantibody in the pathogenesis of preeclampsia. Hypertension 50(1): E3; Author Reply E4-E3; Author Reply E4, 2007

Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity. Hypertension 55(2): 386-393, 2010

Complement Split Products C3a/C5a and Receptors: Are They Regulated by Circulating Angiotensin II Type 1 Receptor Autoantibody in Severe Preeclampsia?. Gynecologic and Obstetric Investigation 81(1): 28-33, 2016

Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling. Hypertension 55(5): 1246-1253, 2010

Linking the old and new -- do angiotensin II type 1 receptor antibodies provide the missing link in the pathophysiology of preeclampsia?. Hypertension in Pregnancy 34(3): 369-382, 2015

Angiotensin receptor agonistic autoantibody-mediated tumor necrosis factor-alpha induction contributes to increased soluble endoglin production in preeclampsia. Circulation 121(3): 436-444, 2010

Angiotensin receptor agonistic autoantibody-mediated soluble fms-like tyrosine kinase-1 induction contributes to impaired adrenal vasculature and decreased aldosterone production in preeclampsia. Hypertension 61(2): 472-479, 2013

Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling. Hypertension 51(4): 1010-1019, 2008

The pathophysiology of preeclampsia involves altered levels of angiogenic factors promoted by hypoxia and autoantibody-mediated mechanisms. Biology of Reproduction 87(2): 36, 2012

Presence of auto-antibody against angiotensin II receptor in pregnant women and its potential role in the development of Preeclampsia. 2007